Evidence map›Paper›PMID 35821227›Full record

ArticleCell death & disease2022

TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1.

Lu Yi, Yanan Hu, Zhixiang Wu, Ying Li, Min Kong, Zhijuan Kang, Bojiao Zuoyuan, Zuocheng Yang

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Recent progress in understanding ferroptosis mechanisms in infectious diseases.Frontiers in cellular and infection microbiology · 2026
    Review
  17. Review
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lu YiDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China.ORCID 0000-0002-6423-8582
Yanan HuDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China.
Zhixiang WuDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China.
Ying LiDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China.
Min KongDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China.
Zhijuan KangDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China.
Bojiao ZuoyuanDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China.
Zuocheng YangDepartment of Pediatrics, Third Xiangya Hospital of Central South University, 410013, Changsha, Hunan, People's Republic of China. yang_zcr@126.com.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CVB3 is a single positive-strand enterovirus, and a common pathogen in myocarditis etiology. Although a number of antiviral candidates are under development, specific targeted therapy is not available for CVB3. Ferroptosis is a new type of regulatory cell death discovered in recent years. In this study, our team provided the first evidence that ferroptosis existed in CVB3 infection in vivo and in vitro by iron overload, and massive accumulation of lipid peroxides. Mechanistically, we construct a classical model of HeLa cells following a time-course infection (6, 12, 24, 36, 48 h) with CVB3 (MOI = 10). We demonstrated that the TFRC gene plays an important role in promoting ferroptosis in CVB3 infection and downregulation of TFRC attenuated the ferroptosis. Interestingly, we observed that TFRC was nuclear translocation induced by the CVB3, which was predominantly localized in the cell membrane, but redistributed to the nucleus during CVB3 infection. Moreover, we found that the transcription factor Sp1 was an essential factor that could bind to the TFRC promoter and upregulate the TFRC transcription. Collectively, these results suggest that the Sp1/TFRC/Fe axis may provide a new target for the development of therapies against CVB3 infection.

Indexed as

Coxsackievirus InfectionsEnterovirus B, HumanFerroptosisSp1 Transcription FactorAntigens, CDCell NucleusHeLa CellsHumansReceptors, TransferrinTranscriptional ActivationUp-RegulationAntigens, CDCD71 antigenReceptors, TransferrinSP1 protein, humanSp1 Transcription Factor

Identifiers

PMID35821227
PMCPMC9276735
OpenAlexW4285098415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.